Accelerated Marfan syndrome model recapitulates established signaling pathways

Summers, 2006, Challenges in the diagnosis of Marfan syndrome, Med J Aust, 184, 627, 10.5694/j.1326-5377.2006.tb00419.x Dietz, 1991, Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene, Nature, 352, 337, 10.1038/352337a0 De Cario, 2018, Role of TGFBR1 and TGFB2 genetic variants in Marfan syndrome, J Vasc Surg, 68, 225, 10.1016/j.jvs.2017.04.071 Pearson, 2008, Report of the National Heart, Lung, and Blood Institute and National Marfan Foundation Working Group on research in Marfan syndrome and related disorders, Circulation, 118, 785, 10.1161/CIRCULATIONAHA.108.783753 Somers, 2016, Analysis of TGFBR1*6A variant in individuals evaluated for Marfan syndrome, Am J Med Genet A, 170A, 1786, 10.1002/ajmg.a.37668 Habashi, 2006, Losartan, an AT1 antagonist prevents aortic aneurysm in a mouse model of Marfan syndrome, Science, 312, 117, 10.1126/science.1124287 Neptune, 2003, Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome, Nat Genet, 33, 407, 10.1038/ng1116 Lucarini, 2009, ACE and TGFBR1 genes interact in influencing the susceptibility to abdominal aortic aneurysm, Atherosclerosis, 202, 205, 10.1016/j.atherosclerosis.2008.04.038 Keane, 2008, Medical management of Marfan syndrome, Circulation, 117, 2802, 10.1161/CIRCULATIONAHA.107.693523 Gao, 2016, The effect of losartan on progressive aortic dilatation in patients with Marfan's syndrome: a meta-analysis of prospective randomized clinical trials, Int J Cardiol, 217, 190, 10.1016/j.ijcard.2016.04.186 Cavanaugh, 2017, A novel murine model of Marfan syndrome accelerates aortopathy and cardiomyopathy, Ann Thorac Surg, 104, 657, 10.1016/j.athoracsur.2016.10.077 Cañadas, 2010, Marfan syndrome. Part 1: pathophysiology and diagnosis, Nat Rev Cardiol, 7, 256, 10.1038/nrcardio.2010.30 Michel, 2018, From genetics to response to injury: vascular smooth muscle cells in aneurysm and dissections of the ascending aorta, Cardiovasc Res, 114, 578, 10.1093/cvr/cvy006 Gomez, 2009, Syndromic and non-syndromic aneurysms of the human ascending aorta share activation of the Smad2 pathway, J Pathol, 218, 131, 10.1002/path.2516 Siegert, 2018, Alterered TGF-β endocytic trafficking contributes to the increased signaling in Marfan syndrome, Biochim Biophys Acta, 1864, 554, 10.1016/j.bbadis.2017.11.015 Doyle, 2012, Matrix-dependent perturbation of TGF-β signaling and disease, FEBS Lett, 586, 2003, 10.1016/j.febslet.2012.05.027 Seger, 1995, The MAPK signaling cascade, FASEB J, 9, 726, 10.1096/fasebj.9.9.7601337 Shaul, 2007, The MEK/ERK cascade: from signaling specificity to diverse functions, Biochim Biophys Acta, 1173, 1213, 10.1016/j.bbamcr.2006.10.005 Holm, 2011, Noncanonical TGF-β signaling contributes to aortic aneurysm progression in Marfan syndrome mice, Science, 332, 358, 10.1126/science.1192149 Tae, 2016, Cardiac remodeling in the mouse model of Marfan syndrome develops into two distinctive phenotypes, Am J Physiol Heart Circ Physiol, 310, H290, 10.1152/ajpheart.00354.2015 Wang, 2015, Angiotensin II increases matrix metalloproteinase 2 expression in human aortic smooth muscle cells via AT1R and ERK1/2, Exp Biol Med, 240, 1564, 10.1177/1535370215576312 Carta, 2009, p38 MAPK Is an early determinant of promiscuous Smad2/3 signaling in the aortas of fibrillin-1 (Fbn1)-null mice, J Biol Chem, 284, 5630, 10.1074/jbc.M806962200